Mary Sontrop is Executive Vice President, Operations at CSL Behing. She was appointed EVP, Operations, CSL Behring in April 2010. Prior to taking up this position Mary was the General Manager, CSL Biotherapies, responsible for all aspects of the company’s vaccines and pharmaceuticals business in Australia and New Zealand. She was also responsible for the supply of influenza vaccines manufactured by CSL to Europe, the USA and other global markets. Sontrop has also held several senior management roles in Europe during CSL’s rapid international growth. From 2000 to 2004 as Head of Quality Management, Assurance and Control and later Chief Operating of ZLB AG (plasma protein business acquired from the Swiss Red Cross), and from 2004 to 2006 as Managing Director of ZLB Behring GmbH at Marburg in Germany. Since joining CSL in 1988, Mary has held a broad range of positions in Australia and Europe and USA. Sontrop is a Bachelor of applied science, a Master of business administration, and has graduate diplomas in health administration and quality management.